Key result
Higher QTc strongly links to LQTS genetic yield, reaching ~62% when QTc exceeds 480 ms.
Why the study?
Following a decade of research genetic testing and the May 2004 transition of congenital LQTS genetic testing into a clinically available molecular diagnostic test, the effect of clinical phenotype on the yield of genetic testing needed to be examined.
Does the clinical phenotype (QTc and clinical diagnostic score) correlate with the yield of genetic testing in patients referred for congenital long QT syndrome?
Cohort (n=541)
Blinded to genetic test results
No
Does the clinical phenotype (QTc and clinical diagnostic score) correlate with the yield of genetic testing in patients referred for congenital long QT syndrome?
Clinical phenotype (specifically QTc interval and clinical diagnostic score) strongly predicts the diagnostic yield of genetic testing for congenital long QT syndrome.
Answers are grounded in this paper and cite their sources.
Higher clinical probability phenotypes raise LQTS genetic testing yield; supports phenotype-guided referral while leaving optimal thresholds open for validation.
Objectives The purpose of this study was to examine the effect of clinical phenotype on the yield of genetic testing for congenital long QT syndrome (LQTS). Background Since the discovery of the first LQTS susceptibility genes in 1995, numerous genotype-phenotype relationships have emerged during the past decade of research genetic testing. In May 2004, LQTS genetic testing became a clinically available molecular diagnostic test. Methods Blinded to genetic test results, analysis of the clinical phenotype was performed in 541 consecutive unrelated patients referred to Mayo Clinic's Sudden Death Genomics Laboratory for LQTS genetic testing from August 1997 to July 2004. Results The yield of genetic testing correlated significantly with the corrected QT interval (QTc) and clinical diagnostic score ranging from 0% when QTc was <400 ms to 62% when QTc was >480 ms (p < 0.0001). Among those with the highest clinical probability, the yield was 72% (89 of 123). The yield fluctuated substantially depending on age at diagnosis in males. Among physicians who referred > or =5 patients, the yield ranged from 0% to 80% (p < 0.0001). Conclusions In this large cohort of unrelated patients referred for LQTS genetic testing, the clinical phenotype strongly correlated with the likelihood of elucidating a pathogenic mutation with the cardiac channel gene screen.
No takes yet. Share an insight, caveat, or question.
Tester et al. (2006) conducted a cohort in Congenital long QT syndrome (LQTS) (n=541). Clinical phenotype (corrected QT interval >480 ms and clinical diagnostic score) vs. Corrected QT interval <400 ms or lower clinical diagnostic score was evaluated on Yield of LQTS genetic testing (elucidating a pathogenic mutation with the cardiac channel gene screen) (p=<0.0001). Clinical phenotype strongly correlated with LQTS genetic testing yield, ranging from 0% when QTc was <400 ms to 62% when QTc was >480 ms, and 72% with highest clinical probability.
Synapse has enriched 10 related papers. Consider them for comparative context: